• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetics of maraviroc, raltegravir, darunavir, and etravirine in the semen of HIV-infected men.

作者信息

Antoniou Tony, Hasan Sumaira, Loutfy Mona R, Kovacs Colin, Brunetta Jason, Smith Graham, Halpenny Roberta, La Porte Charles

出版信息

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):e58-60. doi: 10.1097/QAI.0b013e31827a0d71.

DOI:10.1097/QAI.0b013e31827a0d71
PMID:23328092
Abstract
摘要

相似文献

1
Pharmacokinetics of maraviroc, raltegravir, darunavir, and etravirine in the semen of HIV-infected men.马拉维若、拉替拉韦、达芦那韦和依曲韦林在HIV感染男性精液中的药代动力学。
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):e58-60. doi: 10.1097/QAI.0b013e31827a0d71.
2
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination.
J Antimicrob Chemother. 2011 Aug;66(8):1932-4. doi: 10.1093/jac/dkr219. Epub 2011 Jun 4.
3
Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy.在一名晚期妊娠时基于达芦那韦的高效抗逆转录病毒治疗（HAART）失败的、有多种药物治疗经历的HIV感染女性中，依曲韦林和马拉维若的经胎盘转运情况。
J Antimicrob Chemother. 2013 Aug;68(8):1938-9. doi: 10.1093/jac/dkt095. Epub 2013 Mar 27.
4
Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: results of two drug interaction trials.马拉维若与达芦那韦利托那韦、依曲韦林、依曲韦林-达芦那韦利托那韦在健康志愿者中的药代动力学相互作用：两项药物相互作用试验的结果。
Antimicrob Agents Chemother. 2011 May;55(5):2290-6. doi: 10.1128/AAC.01046-10. Epub 2011 Mar 7.
5
Plasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals.HIV 感染者中每日一次服用达芦那韦/利托那韦和每日一次及两次服用雷特格韦的血浆和细胞内药代动力学。
J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):450-7. doi: 10.1097/QAI.0b013e3182364c67.
6
Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects.阿巴卡韦及其代谢物三磷酸卡波韦在未接受和接受达芦那韦/利托那韦或拉替拉韦治疗的HIV感染受试者中的药代动力学。
Antivir Ther. 2012;17(1):19-24. doi: 10.3851/IMP1910.
7
Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals.接受包含这些抗逆转录病毒药物的治疗方案的 HIV 阳性患者的女性和男性生殖道中总游离型马拉维若、雷特格韦和利匹韦林的穿透率和抗病毒疗效。
J Antimicrob Chemother. 2017 Nov 1;72(11):3167-3171. doi: 10.1093/jac/dkx275.
8
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
J Antimicrob Chemother. 2012 Nov;67(11):2779-81. doi: 10.1093/jac/dks260. Epub 2012 Jul 6.
9
Assessment of the pharmacokinetics of co-administered maraviroc and raltegravir.评估合并应用马拉维若和雷特格韦的药代动力学。
Br J Clin Pharmacol. 2010 Jan;69(1):51-7. doi: 10.1111/j.1365-2125.2009.03546.x.
10
Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients.依曲韦林、雷特格韦和达芦那韦/利托那韦在治疗有经验的患者中的药代动力学。
AIDS. 2010 Oct 23;24(16):2581-3. doi: 10.1097/qad.0b013e32833d89fa.

引用本文的文献

1
Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era.抗逆转录病毒疗法与酒精的相互作用：透视高效抗逆转录病毒治疗时代的睾丸和精液参数
Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):121-135. doi: 10.1007/s13318-017-0438-6.
2
Effect of Monotherapy with Darunavir/Ritonavir on Viral Load in Seminal Fluid, and Quality Parameters of Semen in HIV-1-Positive Patients.达芦那韦/利托那韦单药治疗对HIV-1阳性患者精液中病毒载量及精液质量参数的影响。
PLoS One. 2016 Jul 21;11(7):e0159305. doi: 10.1371/journal.pone.0159305. eCollection 2016.
3
A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges.
整合酶抑制剂拉替拉韦的长效制剂可保护人源化BLT小鼠免受反复高剂量阴道HIV攻击。
J Antimicrob Chemother. 2016 Jun;71(6):1586-96. doi: 10.1093/jac/dkw042. Epub 2016 Mar 21.
4
Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.抗逆转录病毒药物在生殖分泌物及HIV传播解剖部位的药代动力学：对HIV预防的意义
Clin Pharmacokinet. 2014 Jul;53(7):611-24. doi: 10.1007/s40262-014-0148-z.
5
Understanding HIV compartments and reservoirs.了解HIV的区室和储存库。
Curr HIV/AIDS Rep. 2014 Jun;11(2):186-94. doi: 10.1007/s11904-014-0207-y.
6
Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir.整合酶抑制剂多替拉韦的临床药代动力学、药效学及药物相互作用概况
Clin Pharmacokinet. 2013 Nov;52(11):981-94. doi: 10.1007/s40262-013-0093-2.